id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0573-0018,FDA,FDA-2009-D-0573,International Conference on Harmonisation; Addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; Availability,Notice,Notice of Availability,2012-05-18T04:00:00Z,2012,5,2012-05-18T04:00:00Z,,2019-10-23T14:20:14Z,2012-12039,0,0,0900006481013f01
FDA-2009-D-0573-0019,FDA,FDA-2009-D-0573,International Conference on Harmonisation Addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology Derived Pharmaceuticals,Other,Guidance,2012-05-18T04:00:00Z,2012,5,2012-05-18T04:00:00Z,,2024-11-07T22:28:28Z,,1,0,09000064810134f5
FDA-2009-D-0573-0001,FDA,FDA-2009-D-0573,International Conference on Harmonisation; Draft Guidance on Addendum to International Conference on Harmonisation S6,Notice,NAD-Notice of Availability of Data,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,2010-02-02T04:59:59Z,2009-12-17T20:30:17Z,E9-29991,0,0,0900006480a6ca36
FDA-2009-D-0573-0002,FDA,FDA-2009-D-0573,Addendum To ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals S6(R1) - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,2010-02-02T04:59:59Z,2023-12-21T02:00:44Z,,0,0,0900006480a6d52c